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Abstract
Background: Intravenous infusions of glucose and amino acids increase both nitrogen balance and
muscle accretion. We hypothesised that co-infusion of glucose (to stimulate insulin) and essential
amino acids (EAA) would act additively to improve nitrogen balance by decreasing muscle protein
degradation in association with alterations in muscle expression of components of the ubiquitin-
proteasome proteolytic pathway.
Methods: We examined the effect of a 5 day intravenous infusions of saline, glucose, EAA and
glucose + EAA, on urinary nitrogen excretion and muscle protein degradation. We carried out the
study in 6 restrained calves since ruminants offer the advantage that muscle protein degradation
can be assessed by excretion of 3 methyl-histidine and multiple muscle biopsies can be taken from
the same animal. On the final day of infusion blood samples were taken for hormone and metabolite
measurement and muscle biopsies for expression of ubiquitin, the 14-kDa E2 ubiquitin conjugating
enzyme, and proteasome sub-units C2 and C8.
Results: On day 5 of glucose infusion, plasma glucose, insulin and IGF-1 concentrations were
increased while urea nitrogen excretion and myofibrillar protein degradation was decreased. Co-
infusion of glucose + EAA prevented the loss of urinary nitrogen observed with EAA infusions alone
and enhanced the increase in plasma IGF-1 concentration but there was no synergistic effect of
glucose + EAA on the decrease in myofibrillar protein degradation. Muscle mRNA expression of
the ubiquitin conjugating enzyme, 14-kDa E2 and proteasome sub-unit C2 were significantly
decreased, after glucose but not amino acid infusions, and there was no further response to the
combined infusions of glucose + EAA.
Conclusion: Prolonged glucose infusion decreases myofibrillar protein degradation, prevents the
excretion of infused EAA, and acts additively with EAA to increase plasma IGF-1 and improve net
nitrogen balance. There was no evidence of synergistic effects between glucose + EAA infusion on
muscle protein degradation or expression of components of the ubiquitin-proteasome proteolytic
pathway.
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Background
The relative rates of muscle protein synthesis and degrada-
tion are critical for maintaining lean tissue mass and nor-
mal healthy metabolic function [1]. Using tracer
incorporation into muscle, leg amino acid exchange and
whole body measurements, it has been shown that the
combined infusion or ingestion of carbohydrate and pro-
tein/amino acids are needed to increase whole body pro-
tein synthesis rate, to reduce protein degradation, and
thus to elicit a positive net protein balance under resting
conditions [2-5]. In a number of clinical conditions (e.g.
postoperative-surgical trauma, sepsis, starvation) muscle
wasting and negative net protein balance can be prevented
by parenteral or intravenous infusions of glucose and
amino acids but the optimum nutrient infusion mixture
and mechanisms involved, remain to be defined [6].
Acute (3 h) infusions of insulin and BCAA, act synergisti-
cally to increase muscle protein synthesis [7], but there
have been few studies on responses in muscle protein deg-
radation, particularly over chronic periods of several days.
Our previous studies in vitro have demonstrated an addi-
tive inhibitory action of insulin and amino acids on pro-
tein degradation in C2C12 myotubes [8]. Studies in
animals and humans in vivo have failed to support a syn-
ergistic role for acute (3 h) infusions of glucose and amino
acids in muscle protein degradation [7,9,10]. It has been
proposed that insulin and amino acids may influence
muscle protein accretion and degradation only during
prolonged infusions [9].
The ubiquitin 26S proteasome dependent system is the
predominant cellular mechanism for myofibrillar protein
degradation in skeletal muscle [11,12]. Starvation up-reg-
ulates ubiquitin-dependent-proteolysis in muscle and this
can be reversed on refeeding and insulin treatment [9,13]
suggesting increased availability of amino acids and ana-
bolic hormones may play a vital role in the down regula-
tion of ubiquitin proteasome pathway. Targetting of
myofibrillar proteins to the proteasome complex requires
the addition of polyubiquitin chains to the protein sub-
strate. Three enzymes are thought to regulate this process:
ubiquitin activating enzyme E1, ubiquitin-conjugating
enzyme, 14-kDa E2 and ubiquitin-protein ligase E3.
Expression of ubiquitin and 26S proteasome subunits are
thought to adapt to changes in flux through the pathway
rather than being regulatory [1]. Our previous studies in
C2C12 myotubes have implicated the ubiquitin proteas-
ome pathway in the additive effect of insulin and amino
acids on myofibrillar protein degradation [8].
We have employed ruminants to examine the effect of vas-
cular infusions of insulin and branch chain amino acids
on muscle metabolism in vivo [14,15]. Ruminants offer
several advantages over rodents for the study of mecha-
nisms regulating protein metabolism: foregut fermenta-
tion of carbohydrate results in less episodic changes in
plasma glucose and insulin; prolonged infusions of glu-
cose do not produce insulin resistance as reported in rats
[16] due to the reduced expression of Glut 4 in muscle
[17]; the rate of myofibrillar protein degradation can be
assessed from 3-MH excretion. Additionally it is possible
to maintain animals on restricted diets in an inactive state
for long periods and take multiple muscle biopsies from
the same animal.
We therefore conducted an in vivo study to examine the
hypothesis that co-infusion of glucose and EAA would act
synergistically to improve nitrogen balance by decreasing
muscle protein degradation in association with altera-
tions in muscle expression of components of the ubiqui-
tin-proteasome proteolytic pathway. We infused EAA
since this provided the limiting amino acids for protein
deposition and BCAA signals without NEAA which are
normally deaminated to supply carbons for gluconeogen-
esis. We show that prolonged infusion of glucose and EEA
act additively to improve nitrogen balance but that EAA
do not influence the inhibitory effect of glucose on muscle
protein degradation and mRNA levels for the ubiquitin
conjugating enzyme, 14-kDa E2 and proteasome sub-unit
C2.
Methods
Experimental animals
All experimental procedures were conducted in accord
with the principles of the UK Animals (Scientific Proce-
dures) Act 1986. Six Holstein-Friesian  male calves, 4
months of age and weighing 90 ± 1.9 kg were housed sep-
arately in metabolism stalls. Calves were fed a diet of
weaner pellets and hay, (2:1) to restrict their growth rate
to 0.3 kg/day, approximately one third of their growth
potential. Over the experimental period calves were fed an
average of 18 MJoules metabolisable energy and 36 g
nitrogen per day. They were fed twice every day at 8:00
and 16:00 hrs and were given free access to water.
Infusions
Once calves were adapted (1 month) to the diet, they were
allocated at random to the following infusion treatments:
Control (saline), Glucose, EAA, Glucose + EAA. Infusion
treatments were infused continuously for 5 days via jugu-
lar vein catheters using an automated peristaltic pump
(Gilson Minipuls (MP4), Anachem Ltd, Bedfordshire,
UK). Catheters were inserted into both jugular veins
under local anaesthesia, one day prior to the start of the
infusion period. One catheter was used for infusion and
the other for blood sampling. Weights of the infusates
were recorded prior to onset of infusions and at least
thrice a day thereafter to adjust infusion rates, if necessary.
Catheters were monitored for blockage or infection andNutrition & Metabolism 2008, 5:5 http://www.nutritionandmetabolism.com/content/5/1/5
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were flushed through with heparinized saline (50 IU/ml)
twice a day.
Calves were infused with two different glucose infusion
rates; 20 µmol glucose/kg BW/min and 9.6 µmol glucose/
kg BW/min equivalent to 21.6 and 10.4 kCal/kg/day,
respectively, such that six infusions (control, glucose × 2,
EAA, glucose × 2 + EAA) were given in a 3 × 2 factorial
design over a period of 8 weeks. Although the two glucose
infusion rates gave dose dependent increases in plasma
glucose and insulin, there were no differences between
glucose infusion rates in the effects on protein metabo-
lism so results for the two rates have been combined. The
average of the glucose infusion was equivalent to 37% of
metabolisable energy intake. Glucose (Sigma) infusate
was sterilised through 0.45 µm filter and then autoclaved
for 20 min at 15 psi Hg mm/120°C.
The mixture of EAA (Forum Pharmaceuticals & Fine
Chemicals, Surrey) was infused at 0.8 mg/kg BW/min; this
is approximately 50% of the EAA absorption rates into the
portal vein observed for a 90 kg calf [18]. The mixture of
individual EAA was made to achieve the following infu-
sion rates (mg/kg/day) based on the composition
observed in the portal vein of calves [18,19]; isoleucine,
0.117; leucine, 0.159; threonine, 0.085; valine, 0.137;
methionine, 0.056; tyrosine, 0.118; phenylalanine, 012;
tryptophan, 0.023; lysine, 0.165; histidine, 0.047;
arginine, 0.126. The EAA were dissolved in 1.5 litre of
ultra pure water and infused at a rate of approximately 1
ml/min, with the rates adjusted for the differences in the
weight of the calves. Amino acid infusates were filtered
sterile through 0.2 µm filters.
Sampling
On the fifth day of each infusion period, blood samples
(10 ml) were collected every 15 min during the last 6
hours of the infusion, using heparinized syringes. Plasma
was separated immediately and kept at -20°C pending
analysis. Muscle biopsy samples from the hind limbs were
collected under local anaesthesia after the last blood sam-
ple was taken. Biopsy samples (approx 0.5 gm) were taken
from the biceps femoris, carefully avoiding previous biopsy
sites, taken for the other infusion treatments, and snap
frozen in liquid nitrogen and transferred to -80°C freezer
until required. The total urine output of each animal was
collected daily into plastic containers containing 100 ml 6
N HCl during the last four days of the infusion period and
a % 5 sample of urine was kept at -20°C until further anal-
ysis.
Plasma metabolite, hormone and amino acid analysis
Plasma glucose and urea nitrogen levels were measured by
the Trinder method and plasma urea N endpoint, respec-
tively (SIGMA, Poole, Dorset, United Kingdom). Plasma
insulin, IGF-1 and GH concentrations were measured by
radio immunoassay using double antibody method [20].
Plasma amino acid concentrations were measured by ion
exchange chromatography with ninhydrin detection
using a Biochrom 20 amino acid analyser (Biochrom,
Cambridge). Measurement of plasma metabolite and hor-
mones were made on 6 samples taken at hourly intervals
from each animal, except for GH, where samples were col-
lected every 15 min during the last 6 hours of the infusion,
and amino acids where a pooled sample representative of
the 6 hour sampling period, was analyzed. Plasma 3-MH
was measured as described for urinary 3-MH.
Urinary metabolite analysis
Urinary creatinine and urea nitrogen levels were assayed
colorimetrically using SIGMA kits, procedure nos. 555
and 640, respectively. Urinary 3-MH concentration was
measured by HPLC as described by [21]. Urine samples
were deproteinised and derivatised with fluorescamine
(SIGMA F-9015) prior to measurement. Fluorescamine
derivatives of 3-MH are retained on a C18 reverse phase
column and can be eluted using an acetonitrile mobile
phase.
A calibration curve was produced for 3-MH (SIGMA M-
3879) using a set of standards (0.20, 0.15, 0.10, 0.05 and
0.025 mM). Two hundred micro litres of 0.2 M histidinol
(internal standard; SIGMA H-6647) was pipetted in to
200 µl of samples and standards. Samples and standards
were then deproteinized by adding 200 µl of 3 M perchlo-
ric acid followed by centrifugation at 2,300 g for 15 min-
utes at 4°C. Next 400 µl of double distilled H2O, 40 µl of
1.5 M NaOH and 400 µl of 0.2 M Na2B4O7, pH 9.0 were
added into 100 µl of supernatants. Tubes were vortexed
and derivatized with 0.25 ml of fluorescamine (0.16 g/
100 ml acetonitrile). After 30 seconds 400 µl of 2 M HCl
was added in all of the tubes to produce the stable form of
3-MH derivative. Tubes were vortexed again, capped and
incubated at 90°C in water bath for 45 minutes. Samples/
standards were extracted twice with 1.5 ml diethyl ether
(HPLC grade) and bottom aqueous layer was transferred
to HPLC vials (Thomson scientific, Cults, Aberdeen).
Seventy microlitre samples/standards were eluted through
ODS (C – 18 reverse phase) column (Capital HPLC Ltd,
Broxburn, West Lothian U. K.) using binary gradients.
Ammonium acetate (8 mM) and acetonitrile (HPLC
grade) were used as solvent A and B, respectively. The gra-
dient rise was from 0.35 to 0.70 acetonitrile over 11 min-
utes at solvent flow rate of 1.1 ml/minute. Peaks were
detected at 470 nm emission and 380 nm excitation.
Northern blot analysis
Total RNA from muscle biopsy samples was extracted by
the guanidine isothiocyanate method [22]. The ratio ofNutrition & Metabolism 2008, 5:5 http://www.nutritionandmetabolism.com/content/5/1/5
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A260/A280 was approx 2.0, indicating purity of total RNA
preparations. Ten micrograms of RNA was run on 1% aga-
rose formaldehyde denaturing gel, transferred to Gene-
screen™ membrane (NEN Life science products, Inc.
Boston, Massachusetts, USA) and covalently fixed to the
membrane by UV irradiation. The strippable cDNA
probes, for 14-kDa E2 ubiquitin conjugating enzyme, C2
and C8 26S proteasome subunits, polyubiquitin and
GAPDH, (a house keeping gene) were synthesized with
[α-32P] dATP to a specific activity of 109 cpm/µg cDNA
using Ambion Strip EZ DNA kit (AMS Biotechnology Ltd,
Witney Oxon, UK). Unincorporated radioactivity was
removed by passing the synthesized probe through chro-
maspin-30 column (Clonetech laboratories Ltd, Hamp-
shire, UK). Membranes were prehybridised with
Quickhyb hybridisation solution (Stratagene cloning sys-
tem, California, USA) for 20 min at 65°C. Purified probe
containing salmon sperm DNA (Ambion) was denatured
at 90°C for 10 min and transferred to the hybridisation
solution. Probe was then hybridised to the RNA on the
blot for two hours at 65°C. To remove non-specific bind-
ing the blot was washed twice with 2 × SSC/0.1% SDS at
60°C for 15 min each and then once with 1 × SSC/0.1%
SDS at 65°C for 15 min. Autoradiographic signals were
quantified by laser densitometry and expressed relative to
the corresponding GAPDH mRNA value to normalise for
equal loading and transfer of RNA. GAPDH was used
because previous studies with nutrients and hormones
have documented that mRNA level for it remains constant
[23]. Membranes were stripped using Strip EZ kit and
rehybridised with other components of the ubiquitin pro-
teasome pathway as described above. Autoradiographic
signals for the 1.2 and 2.6 kb transcripts for 14-kDa E2
and polyubiquitin, respectively were normalised for
GAPDH expression and presented as arbitrary values.
Calculations and statistics
Myofibrillar protein degradation was estimated by
expressing 3-MH urinary excretion rates relative to urinary
creatinine excretion to compensate for differences in the
muscle 3-MH pool size. Net nitrogen balance is the differ-
ence between digested nitrogen intake (assuming a nitro-
gen digestibility of 0.85) and urinary nitrogen excretion.
Results from the two glucose infusion rates were pooled
since there were no differences in the effects on protein
metabolism. Differences of means were determined by
two-way analysis of variance using general linear model
(Minitab version 13.1, Pennsylvania, PA, USA). Post hoc
comparisons were performed by Tukey's pair wise com-
parison for multiple treatments. A regression analysis was
conducted to determine any correlation between parame-
ters.
Results
Calves were fed a diet to restrict growth rate to increase the
sensitivity of muscle protein degradation to the infusion
treatments. Our previous study [15] has demonstrated
that acute infusions of insulin and BCAA improves muscle
protein balance in sheep fed at maintenance energy intake
but the length of the current experiment necessitated feed-
ing slightly above maintenance. Animals consumed their
entire ration and achieved a metabolisable energy intake
that was 29% higher than the metabolisable energy
requirement for maintenance. This restricted feed intake
resulted in a linear increase in live weight over the three
months of the experiment of 0.3 ± 0.04 kg/d, approxi-
mately one third of their potential maximum rate of
growth
Intravenous infusion of glucose caused an increase in
average plasma glucose and insulin concentrations over
the last 6 hours of the 5 day infusion period (P < 0.05;
Table 1). There was no significant variation between the
hourly samples taken over the 6 hours for plasma glucose
and insulin (results not shown). The increases in plasma
glucose (34%) and insulin (83%) were well within the
physiological range. Infusion of EAA alone or in addition
to glucose did not significantly alter plasma glucose or
insulin concentrations compared to control or glucose
infusion, respectively. Plasma IGF-1 was increased (73%)
by glucose infusion, not altered by EAA infusion and co-
infusion of glucose + EAA elicited an additional increase
(106%) in IGF-1 concentration compared with glucose
alone (P < 0.05; Table 1). There were no significant effects
of infusions on mean plasma growth hormone (Table 1)
but there was evidence of increased variation in plasma
Table 1: Mean plasma metabolites and hormones concentrations in calves over the final 6 hours of a five day intravenous infusion of 
saline (control); glucose; essential amino acids (EAA) and glucose + EAA.
Control Glucose EAA EAA+Glucose
Glucose mmol/L 4.1a ± 0.20 5.5bc ± 0.17 4.4ac ± 0.14 5.3c ± 0.20
Insulin ng/ml 0.6a ± 0.03 1.1b ± 0.10 0.6a ± 0.05 0.9a ± 0.10
IGF – 1 ng/ml 38.8a ± 5.5 67.2c ± 6.03 47.4ac ± 3.93 80.0b ± 6.55
GH ng/ml 5.4a ± 0.81 5.8a ± 0.50 4.7a ± 0.50 5.3a ± 0.34
Values are averages of 6 blood samples taken at hourly intervals except for GH where samples were collected every 15 min during the last 6 hours 
of the infusion. Values are means ± standard error of the mean (SEM). a,b,c Values within the same row with different superscripts are significantly 
different (P < 0.05)Nutrition & Metabolism 2008, 5:5 http://www.nutritionandmetabolism.com/content/5/1/5
Page 5 of 9
(page number not for citation purposes)
GH concentration over the sampling period during the
glucose and glucose + EAA infusions suggesting increased
pulsatility (results no shown).
Infusion of glucose depressed the average concentrations
of amino acids in pooled plasma taken from hourly sam-
ples. This effect was significant for EAA, and when just
BCAA were considered, whether glucose was infused with
or without EAA (P < 0.05; Table 2). Analyses of individual
amino acids showed that the infusion effects on plasma
BCAA concentrations were due to parallel changes in indi-
vidual BCAA (leucine, isoleucine and valine). Plasma con-
centrations of, the essential amino acids, phenylalanine,
methionine, lysine, histidine, arginine and threonine
were significantly increased during the EAA infusion (P <
0.05). Glucose infusion increased the plasma concentra-
tions of some non-essential amino acids (serine, aspar-
tate, glycine), and decreased proline and the urea cycle
intermediates, citrulline and ornithine (P < 0.05; Table 2).
EAA infusion decreased circulating levels of serine, aspar-
tate, proline and glycine while increasing ornithine.
Plasma urea nitrogen concentrations were significantly (P
< 0.05 Table 3) decreased after glucose infusion and were
increased (P < 0.05; Table 3) following EAA infusions.
Glucose infusion decreased urinary nitrogen excretion
and this effect was also observed when glucose was co-
infused with EAA, (P < 0.05; Table 3). Urinary nitrogen
excretion was increased during EAA infusion such that
approximately 50% of the infused EAA nitrogen was
excreted. There was a further decrease in urinary nitrogen
excretion when glucose and EAA were co-infused with the
result that excretion of infused EAA nitrogen was reduced
to zero (Table 3). A significant correlation between
plasma urea and urinary nitrogen excretion was observed
(P < 0.001; results not shown).
Plasma 3-MH concentration was significantly (P < 0.05)
decreased during infusions of glucose and EAA (Table 3).
Urinary 3-MH excretion, was corrected for animal differ-
ences in muscle mass by expressing relative to creatinine
excretion (3-MH:creatinine), to provide an estimation of
skeletal muscle proteolysis. This ratio was significantly
decreased after glucose infusion (P < 0.05; Table 3) but co-
infusion of EAA did not alter the extent of the inhibitory
effect of glucose. Creatinine excretion was not signifi-
cantly altered by any of the treatments (results not
shown). A linear relationship between plasma and urinary
Table 2: Mean plasma amino acids concentrations (µmol/L) in calves on the final day of a five day intravenous infusion of saline 
(control); glucose; essential amino acids (EAA) and glucose + EAA.
Control Glucose EAA EAA+Glucose
Leucine 135a ± 7.83 69.8c ± 5.22 239.6b ± 13.15 155a ± 12.05
Isoleucine 110a ± 6.04 59.1c ± 4.09 193.6b ± 7.09 131a ± 8.77
Valine 252a ± 14.31 135c ± 11.39 465.9b ± 24.50 298d ± 19.09
Histidine 50.5a ± 1.96 30.8c ± 2.79 70.3b ± 1.50 68.6b ± 2.93
Phenylalanine 60.9a ± 2.60 49.0a ± 2.62 186.4b ± 6.78 185b ± 9.80
Tyrosine 50.9a ± 2.60 43.6a ± 4.15 67.5b ± 7.04 86.1b ± 6.81
Methionine 15.8a ± 1.31 11.4a ± 1.10 34.7b ± 2.17 36.9b ± 2.03
Arginine 129a ± 8.26 78.6c ± 6.99 169.9b ± 3.39 166b ± 7.54
Lysine 118a ± 7.87 56.9c ± 5.18 186.1b ± 8.84 166b ± 10.5
Threonine 111a ± 7.68 80.2a ± 7.61 179.7b ± 11.49 202b ± 11.24
Tryptophan 34.9ac ± 2.89 27.7a ± 1.87 41.7bc ± 1.07 44.7bc ± 1.68
Serine 76.4 ± 6.15 101 ± 7.29 62.8 ± 4.26 80.7 ± 4.33
Aspartate 25.7 ± 0.89 28.1 ± 0.38 18.8 ± 1.42 21.6 ± 0.98
Asparagine 29.0 ± 2.26 26.1 ± 1.64 22.7 ± 1.65 25.5 ± 1.06
Glutamate 137 ± 12.71 110 ± 5.47 118 ± 9.23 131 ± 8.17
Glutamine 188 ± 13.45 197 ± 10.13 154 ± 9.50 164 ± 9.04
Proline 77.5 ± 3.90 63.0 ± 3.02 63.1 ± 2.99 63.4 ± 2.02
Glycine 221 ± 27.55 386 ± 23.55 156 ± 23.12 292 ± 26.17
Alanine 228 ± 5.79 142 ± 9.72 171 ± 11.77 159 ± 8.40
Citrulline 73.4 ± 5.28 52.6 ± 3.19 77.6 ± 9.05 66.2 ± 3.54
Ornithine 101 ± 8.03 52.2 ± 4.16 117 ± 9.05 84.7 ± 5.71
TAA 2272abc ± 80.10 1842ab ± 106.30 2837c ± 74.53 2687bc ± 117.92
BCAA 497a ± 2.95 264b ± 27.06 899c ± 41.74 584ac ± 33.92
EAA 1018a ± 39.72 598b ± 57.86 1767c ± 37.42 1336d ± 78.87
NEAA 1259 ± 52.10 1243a ± 7.99 1086a ± 48.99 1233a ± 7.99
6 plasma samples were taken at hourly intervals during the last 6 hours of the infusion and pooled prior to analysis. TAA, total amino acids; BCAA, 
branched chain aminoacids; NEAA, non-essential amino acids. Values are means ± standard error of the mean (SEM). a,b,c Values within the same 
row with different superscripts are significantly different (P < 0.05).Nutrition & Metabolism 2008, 5:5 http://www.nutritionandmetabolism.com/content/5/1/5
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3-MH concentrations was also observed (P < 0.001;
results not shown). Estimation of net nitrogen balance
assuming a digestible N intake of 25 gN/day and includ-
ing infused amino N, gave values (g/kg/day) of 0.522
(control); 0.80 (glucose); 1.06 (EAA); 1.66 (glucose +
EAA). Therefore co-infusion of glucose and EAA improved
nitrogen balance more effectively than individual nutrient
infusions.
Expression of ubiquitin conjugating enzyme, 14-kDa E2,
and the proteasome sub-unit C2, in skeletal muscle (Fig-
ure 1) were significantly reduced after glucose infusion,
but not EAA, compared to the control (P < 0.05). There
were no significant effects of infusions on muscle mRNA
levels of polyubiquitin or the proteasome sub-unit C8
(Figure 1). There was no evidence of synergism between
Table 3: Mean plasma concentration and urinary excretion of urea nitrogen and 3-methylhistidine (3-MH) in calves on the final day of a 
five day intravenous infusion of saline (control); glucose; essential amino acids (EAA) and glucose + EAA.
Control Glucose EAA EAA+Glucose
Plasma Urea N mmol/L 8.8a ± 0.91 5.8b ± 0.37 11.0c ± 0.79 6.7ab ± 0.51
Plasma 3-MH µmol/L 3.3a ± 0.36 1.6b ± 0.24 1.9b ± 0.61 1.9b ± 0.13
Urinary Urea N g/d 16.8a ± 1.06 12.4b ± 1.19 25.3c ± 3.70 15.8ab ± 1.71
Urinary 3-MH:Creatinine mg/g 13.3a ± 0.51 12.2b ± 0.33 12.5a ± 0.24 12.2a ± 0.22
Net Nitrogen Balance g/kg/d 0.52 0.80 1.06 1.66
Values are averages of 6 blood samples taken at hourly intervals during the last 6 hours of the infusion or pooled urine collected over the last 4 days 
of infusion. Net nitrogen balance is the difference between digested nitrogen intake (assuming a nitrogen digestibility of 0.85) and urinary nitrogen 
excretion. Values are means ± standard error of the mean (SEM). a,b,c Values within the same row with different superscripts are significantly 
different (P < 0.05).
Expression of the genes encoding components of the ubiquitin proteasome proteolytic pathway Figure 1
Expression of the genes encoding components of the ubiquitin proteasome proteolytic pathway. Muscle biopsies 
were taken from calves on the final day of a five day intravenous infusion of saline (control); glucose and essential amino acids 
(EAA). 10 µg of muscle RNA was blotted on a nylon membrane and hybridised against cDNA probes for 14-kDa E2, polyubiq-
uitin, C2 and C8 as described under experimental procedures. A; values are means, normalised to GAPDH, +/- SEM, and rep-
resented as arbitrary units. B; representative northern blots.Nutrition & Metabolism 2008, 5:5 http://www.nutritionandmetabolism.com/content/5/1/5
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glucose and insulin on expression of components of the
ubiquitin-proteasome pathway.
Discussion
Our study showed that a 5 day intravenous infusion of
glucose, sufficient to achieve physiological increases in
plasma glucose, insulin and IGF-1 concentrations,
improves whole body nitrogen balance, inhibits myofi-
brillar protein degradation and decreases the expression
of components of the ubiquitin proteasome pathway in
muscle of normal calves. Infusion of EAA also improved
net nitrogen balance but without significant changes in
plasma insulin, IGF-1, growth hormone concentrations or
muscle protein degradation. We demonstrated a synergis-
tic effect between co-infused glucose and EAA which pre-
vented all of the infused EAA nitrogen from being excreted
in urine, but this synergism between glucose and EAA is
not due to effects on muscle protein degradation.
Several studies have examined the effects of glucose and
amino acid intravenous infusions on nitrogen retention
in animals and humans [24-26]. The advantage of supply-
ing glucose is that it is insulinogenic without causing
hypoglycaemia, it suppresses non-essential amino acid
utilisation for gluconeogenesis and it supplies energy
[26]. We report the first study which compares the effects
of glucose with infusion of a physiological mixture of only
EAA, thereby targeting amino acids to retention in body
tissues without the need for deamination of non-essential
amino acids. We also report effects of chronic 5 day infu-
sions on myofibrillar protein degradation since parenteral
infusions are normally given over extended periods of sev-
eral days. Previous studies have examined acute nutrient
infusions and may give misleading results as several stud-
ies have reported transient responses in protein turnover
to amino acid infusion [25,27,28].
Glucose infusion alone caused a significant drop in urea
synthesis as observed in the decreases in plasma urea lev-
els and urinary urea nitrogen excretion. When the equiva-
lent of 17 gN/day was infused as EAA, 8.5 gN/day or 50%
was excreted in the urine, the remaining being retained in
body tissues. When glucose was co-infused with EAA, urea
nitrogen excretion and plasma urea levels decreased
below the control values indicating that all the infused
EAA were retained. Estimation of net nitrogen balance
demonstrated that glucose infusion alone increased N
balance by 4.4 compared with 9.5 gN/day when glucose
and EAA were co-infused. Previous work has demon-
strated that glucose combined with amino acids given to
preoperative patients is the most effective at improving
nitrogen balance although these effects occurred without
alterations in myofibrillar protein degradation
[6,25,26,29,30].
Most studies on the mechanisms by which insulin and
amino acids improve protein balance have examined the
effects on muscle protein synthesis rather than degrada-
tion. Although insulin has been identified as a stimulator
of protein synthesis [31], several studies employing
amino acid flux determinations in humans, have demon-
strated that short-term (up to 3 h) supraphysiological
administration of insulin inhibits both whole body pro-
tein breakdown and skeletal muscle breakdown [32-
34,10,35,36]. We measured plasma 3-MH concentration
and urinary 3-MH excretion to assess the degradation of
myofibrillar proteins in muscle and demonstrated that the
increase in nitrogen balance during glucose infusion was
accompanied by a significant decrease in muscle protein
degradation.
In vitro experiments have shown that insulin down regu-
lates proteasome-dependent proteolysis [8,13,37]. The
results of our studies here are in agreement with this pro-
posal and demonstrate for the first time that a prolonged
5 day glucose infusion decreases the muscle expression of
components of the ubiquitin proteasome pathway. In
response to glucose infusion, we observed significant
decreases in ubiquitin-conjugating enzyme 14-kDa E2
mRNA and C2 proteasome sub unit, and a small trend for
a decrease in Ubiquitin and the C8 proteasome sub unit.
Both the ubiquitin-conjugating enzyme E2 and ubiquitin-
protein ligase E3 have been suggested to regulate the rate
of protein substrate degradation by the proteasome com-
plex [38] while expression of ubiquitin and 26S proteas-
ome subunits are thought to adapt to changes in flux
through the pathway rather than being regulatory.
Despite the additive effect between co-infused glucose
and EAA on nitrogen excretion and nitrogen balance,
these treatments did not further decrease myofibrillar pro-
tein degradation values or the expression of components
of the ubiquitin proteasome pathway, observed with glu-
cose only infusion. Acute infusion experiments in vivo in
humans and rodents [9,33], have provided conflicting evi-
dence for a synergistic effect of amino acids on insulin
suppression of muscle proteolysis. It has been suggested
that proteasome-dependent muscle proteolysis may only
respond over a longer time period (10 h) to nutrients [9]
but this was not apparent in our study. These in vivo stud-
ies contrast with our C2 C12 in vitro experiments which
show that amino acids enhance the inhibitory effects of
insulin on proteolysis and that this effect involves both
the suppression of ubiquitin-dependent proteolysis and is
associated with reduced E2 expression [8].
Acute (3–5 h) amino acid infusion in to humans has been
reported to decrease protein breakdown in skeletal muscle
and splanchnic tissue [39,40] but other have failed to con-
firm these findings [41,42]. Volpi et al. (1998) [43]Nutrition & Metabolism 2008, 5:5 http://www.nutritionandmetabolism.com/content/5/1/5
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showed that amino acid infusion did not effect the degra-
dation of myofibrillar proteins, measured by 3-methylhis-
tidine release in elderly humans under conditions where
they did not observe any change in plasma concentration
of insulin and IGF-1.
Studies in healthy humans have demonstrated the stimu-
latory effect of infused amino acids or high dietary protein
intake on skeletal muscle protein synthesis [43,44]. The
synergistic effect of glucose and EAA in nitrogen retention
may therefore be due to stimulation of muscle protein
synthesis. In rodents, acute BCAA infusions stimulate the
sensitivity of muscle protein synthesis to the anabolic
effects of co-infused insulin [7]. Our in vivo studies in
maintenance-fed sheep [14] failed to confirm these find-
ings while Bohe et al. (2003) [28] have demonstrated that
the response of human muscle protein synthesis to
increased availability of amino acids in plasma, is tran-
sient.
Co-infusion of glucose and EAA may also have altered
protein turnover in tissues other than muscle since
Nygren and Nair, (2003) [40], showed that amino acids
have an inhibitory effect on splanchnic protein break-
down which was independent of insulin. Suppression of
proteolysis observed in vivo may also be mediated through
the autophagic pathway since in liver and visceral tissues,
this is the major proteolytic pathway, and is sensitive to
amino acid regulation, independent of insulin [45].
The additive effect of glucose and EAA on nitrogen reten-
tion was accompanied by a similar effect on plasma IGF-
1 concentrations. Our previous studies in sheep have
demonstrated that that prolonged (5 day) glucose infu-
sion is able to induce an IGF-1 secretory response to GH
administration only when dietary protein intake is
increased [46]. Several studies in patients undergoing sur-
gery have demonstrated that increased IGF-1 levels are
associated with improved nitrogen balance [47]. Furthe-
more improvements in postoperative N balance due to AA
infusion have been associated with increased IGF-1 in
plasma [48]. These responses may be due to changes in
muscle protein synthesis, since IGF-1 administration to
rats does not inhibit muscle proteolysis [49])
Conclusion
We conclude that chronic 5-day intravenous infusions of
glucose and EAA in calves act synergistically to improve
whole body nitrogen balance but although glucose infu-
sion decreased myofibrillar protein degradation and mus-
cle expression of components of the ubiquitin
proteasome pathway, the synergism between glucose and
EAA is not due to effects on muscle protein degradation.
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